Internal Medicine, Hematology · Philadelphia, PA
NPI
1366486250
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3400 Spruce St, 15 Penn Tower
Philadelphia, PA, 19104
Phone (215) 662-3914
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
284 services
Medicare patients, 2024
128
Average age 72
Drug cost, 2024
$7.8M
686 prescriptions
Company payments, 2025
$2,332
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth O Hexner was code 99214 (office e&m - established), 108 times for 77 patients. In total Elizabeth O Hexner billed 284 services in 14 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 108 | 77 | $69.03 | $7,455 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 43 | 40 | $13.33 | $573 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 15 | $63.73 | $2,103 |
| 99215 Office E&M - Established | Facility | 30 | 26 | $108.93 | $3,268 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 15 | $95.86 | $2,013 |
| 99213 Office E&M - Established | Facility | 14 | 13 | $44.83 | $628 |
By year: 2022 $20K for 234 services; 2023 $28K for 327 services; 2024 $19K for 284 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth O Hexner prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 201 prescriptions and refills. In total Elizabeth O Hexner wrote 686 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 201 | 201 | 21 | $3.2M |
| Hydroxyurea Generic | 107 | 252 | 28 | $2,696 |
| Ayvakit Avapritinib | 75 | 75 | Under 11 | $3.1M |
| Famotidine Generic | 37 | 53 | Under 11 | $169 |
| Besremi Ropeginterferon Alfa-2b-Njft | 27 | 27 | Under 11 | $452K |
| Escitalopram Oxalate Generic | 21 | 31 | Under 11 | $115 |
| Acyclovir Generic | 17 | 31 | Under 11 | $479 |
| Levothyroxine Sodium Generic | 14 | 24 | Under 11 | $65.09 |
| Cromolyn Sodium Generic | 14 | 20 | Under 11 | $1,606 |
| Sprycel Dasatinib | 13 | 13 | Under 11 | $132K |
| Cetirizine Hcl Generic | 11 | 11 | Under 11 | $506 |
| Xarelto Rivaroxaban | 11 | 11 | Under 11 | $5,718 |
Brand drugs: 367 claims; generic drugs: 319 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth O Hexner $2,332 ($2,332 in general payments such as food, travel and fees) from 3 companies. The largest payer was Blueprint Medicines Corporation with $2,332.
| Company | Payments | Amount |
|---|---|---|
| Blueprint Medicines Corporation SNY | 1 | $2,332 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.